RCSLT and Wiley-Blackwell partner to publish 'International Journal of Language and Communication Disorders'

NewsGuard 100/100 Score

The Royal College of Speech and Language Therapists has partnered with Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc. (NYSE: JWa), (NYSE: JWb), to publish their journal International Journal of Language and Communication Disorders (IJLCD), starting in 2011.

The RCSLT is the professional body for speech and language therapists in the UK and has over 14,000 members. It is responsible for setting, promoting and maintaining high standards in education, clinical practice and ethical conduct in the discipline. Together Wiley-Blackwell and the RCSLT will develop the journal to benefit all those working in speech, language and communication careers—in their learning, teaching, research and professional practice.

Philip Carpenter, Vice-President at Wiley-Blackwell states, "We are very pleased to be partnering with The Royal College of Speech and Language Therapists to publish IJLCD, and to further support their academic and professional work in the areas of speech, language, and communication. With this partnership we are strengthening our existing offerings in allied health and communication disorders."

Kamini Gadhok, Chief Executive of the Royal College of Speech and Language Therapists, remarks, "We are delighted to have chosen Wiley-Blackwell as the publishers of the IJLCD. We look forward to seeing the benefits of their worldwide contacts and innovative marketing approaches to the benefit of RCSLT members, their clients and the dissemination of the latest scientific developments in the field of speech, language, and communication."

The partnership reinforces Wiley-Blackwell's already prominent position as publisher for more than 750 society partners, including many allied health associations and professional bodies working globally.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Chatbots for mental health pose new challenges for US regulatory framework